Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05012475 · ClinicalTrials.gov registry record · NA
Measuring Impact of Computer Gaming on Arm Use in Rett Syndrome
A NA study of Rett Syndrome, sponsored by Georgetown University.
- Recruiting
- Registry status
- NA
- Development phase
- 10
- Enrollment target
- 1
- Study location
NCT05012475: Recruiting NA study of Rett Syndrome, sponsored by Georgetown University.
NCT05012475 is a NA study of Rett Syndrome that is actively recruiting participants, run by Georgetown University. The registered enrollment target is 10 participants, below the 525-participant average among 18 other Rett Syndrome trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05012475, a NA study of Rett Syndrome, is actively recruiting participants, sponsored by Georgetown University.
- RECRUITING
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
- 1
- Study location
Study Summary
Using a tele-research approach, we will recruit, enroll, guide and support carers and participants to engage in computer based activities (modified virtual reality) with the primary outcome of reducing stereotypies and increasing independent arm and hand use and secondary outcome of improving quality of living. Because of our virtual approach, we are able to recruit from multiple countries and all states and territories of the USA.
Primary Outcome
Investigators will video record all testing sessions so that the video can be viewed slow motion or frame by frame to count hand separations, number of reaches, time of sustained reaches, and sustained hand separations.
Conditions Studied
Interventions
- BEHAVIORAL Modified Virtual Reality Gaming
Study Locations (1)
District of Columbia
- Georgetown University School of Medicine - Washington D.C.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2021-05-01 |
| Est. Completion | 2025-12-01 |
| Phase | NA |
What NCT05012475 shows while recruiting
NCT05012475 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 525-participant average among 18 other Rett Syndrome trials with a reported enrollment target (98% lower).
The record links to 1 condition, with Rett Syndrome appearing as the primary indexed condition, and to 1 intervention - of which Modified Virtual Reality Gaming is the first listed.
NCT05012475 reports a single indexed study location in District of Columbia.
Frequently Asked Questions
What is clinical trial NCT05012475 about?
NCT05012475 is a clinical study titled "Measuring Impact of Computer Gaming on Arm Use in Rett Syndrome". Using a tele-research approach, we will recruit, enroll, guide and support carers and participants to engage in computer based activities (modified virtual reality) with the primary outcome of reducing stereotypies and increasing independent arm and hand use and secondary outcome of improving qualit...
What is the current status of trial NCT05012475?
This trial is currently recruiting. It is a NA study. The enrollment target is 10 participants. The study started on 2021-05-01. Estimated completion is 2025-12-01.
What conditions does trial NCT05012475 study?
This clinical trial studies the following conditions: Rett Syndrome.
What interventions are being tested in trial NCT05012475?
The interventions under investigation include: Modified Virtual Reality Gaming (BEHAVIORAL).
Who is sponsoring clinical trial NCT05012475?
This trial is sponsored by Georgetown University, which has 227 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05012475 being conducted?
This trial has 1 study location across District of Columbia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Rett Syndrome
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05012475's enrollment target sits among peer trials
10 18th of 18 higher than 1 of 18 other Rett Syndrome trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Rett Syndrome trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Web Intervention for Parents of Youth With Genetic Syndromes (WINGS)
RECRUITING · NA
-
Technology-supported Motor Rehabilitation for People With Rett Syndrome
ACTIVE NOT RECRUITING · NA
-
Rett Syndrome Registry
RECRUITING
-
Cognitive Function in Rett Syndrome During Trofinetide Treatment
RECRUITING
-
Validating Innovative Biosensors for Rett Autonomic Symptom Tracking
RECRUITING
-
The Rett Syndrome Global Registry
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI